Current situation and future of stem cells in cardiovascular medicine

M.I. Nasser,Xiao Qi,Shuoji Zhu,Yin He,Mingyi Zhao,Huiming Guo,Ping Zhu
DOI: https://doi.org/10.1016/j.biopha.2020.110813
2020-12-01
Abstract:<p>Cardiovascular disease (CVD) is one of the leading causes of death worldwide. Currently, many methods have been proposed by researchers for the prevention and treatment of CVD; among them, stem cell-based therapies are the most promising. As the cells of origin for various mature cells, stem cells have the ability to self-renew and differentiate. Stem cells have a powerful ability to regenerate biologically, self-repair, and enhance damaged functional tissues or organs. Allogeneic stem cells and somatic stem cells are two types of cells that can be used for cardiac repair. Theoretically, dilated cardiomyopathy and acute myocardial infarction can be treated with such cells. In addition, stem cell transplantation procedures, including intravenous, epicardial, cardiac, and endocardial injections, have been reported to provide significant benefits in clinical practice; however, there are still a number of issues that need further study and consideration, such as the form and quantity of transplanted cells and post-transplantation health. The goal of this analysis was to summarize the recent advances in stem cell-based therapies and their efficacy in cardiovascular regenerative medicine.</p>
pharmacology & pharmacy,medicine, research & experimental
What problem does this paper attempt to address?